Cost-effectiveness of dual-chamber pacemaker therapy: Does single lead VDD pacing reduce treatment costs of atrioventricular block?

European Heart Journal

Volumn 22, Issue 2, 2001, Pages 174-180

  Wiegand, Uwe K H ^a   Potratz, J ^a   Bode, F ^a   Schreiber, R ^b   Bonnemeier, H ^a   Peters, W ^a   Katus, H A ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Department of Finances ^*  (Germany)

Author keywords

Complications; Cost effectiveness; Dual chamber pacing; Single lead VDD pacing

Indexed keywords

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE COST; HEART PACING; HUMAN; IMPLANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PRIORITY JOURNAL; SINUS NODE; SURVIVAL; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; CARDIAC PACING, ARTIFICIAL; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HEART BLOCK; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL;

EID: 0034943668     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2126     Document Type: Article

References (27)

1. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing
2. Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without preexistent congestive heart failure
3. Longevity in patients with high degree atrioventricular block paced in the atrial synchronous or the fixed rate ventricular inhibition mode
4. Cardiac output in single-lead VDD pacing versus rate-matched VVIR pacing
5. Recommendations for pacemaker prescription for symptomatic patients
6. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmic devices: A report of the ACC/AHA Task Force on Practice Guidelines (Committee on Pacemaker Implantation)
7. Cost implications of the British Pacing and Electrophysiology Group's recommendations for pacing
8. Impact of the recommendations of the British Pacing and Electrophysiology Group on pacemaker prescription and on the immediate costs of pacing in the Northern Region
9. Cost benefit analysis of single and dual chamber pacing for sick sinus syndrome and atrioventricular block. An economic sensitivity analysis of the literature
10. Atrial sensing and AV-synchrony in single-lead VDD-pacemakers. A prospective comparison to DDD-devices with bipolar atrial leads
11. Long-term reliability of single lead atrial synchronous pacing systems using closely spaced atrial dipoles: Five year experience
12. European multicenter prospective follow-up study of 1002 implants of a single-lead VDD pacing system
13. A multicenter evaluation of a single-pass lead VDD system
14. Long-term follow-up of patients with single lead VDD stimulation
15. The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations
16. Insulation lead failure: Is it a matter of insulation coating, venous approach, or both?
17. Early complications of permanent pacemaker implantation: No difference between dual and single chamber systems
18. DDD pacing mode survival in patients with a dual-chamber pacemaker
19. Dual chamber pacing: How many patients remain in DDD-mode over a long term?
20. Long term performance of atrial leads
21. Prospective randomised trial of atrial versus ventricular pacing in sick sinus syndrome
22. Occurrence of sinus node disease in patients with AV-block. Implications for single-lead VDD-pacing
23. Reasons for reprogramming dual chamber pacemakers to VVI mode: A retrospective review using a computer database
24. Long-term survival of VDD pacing
25. Reprogramming pacemakers enhances longevity and is cost-effective